EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Rosavin in the Pathophysiology of Bone Metabolism

Piotr Wojdasiewicz iD, Paweł Turczyn iD, Anna Lach-Gruba, Łukasz A Poniatowski, Daryush Purrahman iD, Mohammad-Reza Mahmoudian-Sani, Dariusz Szukiewicz iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25042117 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Piotr Wojdasiewicz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, …. Hauptthemen laut MEDLINE: Osteoclasts, Bone Resorption, Disaccharides. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rosavin, a phenylpropanoid in Rhodiola rosea’s rhizome, and an adaptogen, is known for enhancing the body’s response to environmental stress. It significantly affects cellular metabolism in health and many diseases, particularly influencing bone tissue metabolism. In vitro, rosavin inhibits osteoclastogenesis, disrupts F-actin ring formation, and reduces the expression of osteoclastogenesis-related genes such as cathepsin K, calcitonin receptor (CTR), tumor necrosis factor receptor-associated factor 6 (TRAF6), tartrate-resistant acid phosphatase (TRAP), and matrix metallopeptidase 9 (MMP-9). It also impedes the nuclear factor of activated T-cell cytoplasmic 1 (NFATc1), c-Fos, the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and mitogen-activated protein kinase (MAPK) signaling pathways and blocks phosphorylation processes crucial for bone resorption. Moreover, rosavin promotes osteogenesis and osteoblast differentiation and increases mouse runt-related transcription factor 2 (Runx2) and osteocalcin (OCN) expression. In vivo studies show its effectiveness in enhancing bone mineral density (BMD) in postmenopausal osteoporosis (PMOP) mice, restraining osteoclast maturation, and increasing the active osteoblast percentage in bone tissue. It modulates mRNA expressions by increasing eukaryotic translation elongation factor 2 (EEF2) and decreasing histone deacetylase 1 (HDAC1), thereby activating osteoprotective epigenetic mechanisms, and alters many serum markers, including decreasing cross-linked C-telopeptide of type I collagen (CTX-1), tartrate-resistant acid phosphatase 5b (TRACP5b), receptor activator for nuclear factor κ B ligand (RANKL), macrophage-colony-stimulating factor (M-CSF), and TRAP, while increasing alkaline phosphatase (ALP) and OCN. Additionally, when combined with zinc and probiotics, it reduces pro-osteoporotic matrix metallopeptidase 3 (MMP-3), interleukin 6 (IL-6), and tumor necrosis factor α (TNF-α), and enhances anti-osteoporotic interleukin 10 (IL-10) and tissue inhibitor of metalloproteinase 3 (TIMP3) expressions. This paper aims to systematically review rosavin’s impact on bone tissue metabolism, exploring its potential in osteoporosis prevention and treatment, and suggesting future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsBone ResorptionDisaccharidesAnimalsMiceTartrate-Resistant Acid PhosphataseOsteogenesisCell DifferentiationNF-kappa BMetalloproteasesRANK LigandNFATC Transcription Factors

Stichwörter der Autor:innen

Rhodiola roseaadaptogensbone lossbone metabolismosteoblastsosteoclastogenesisosteogenesisosteoporosisrosavin

Substanzen

rosavinTartrate-Resistant Acid PhosphataseNF-kappa BMetalloproteasesRANK LigandNFATC Transcription FactorsDisaccharides

Autor:innen und Institutionen

  • Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
  • Department of Early Arthritis, Eleonora Reicher National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, Poland.
  • Department of Rehabilitation, St. Anna's Trauma Surgery Hospital, Mazovian Rehabilitation Center-STOCER, Barska 16/20, 02-315 Warsaw, Poland.
  • Department of Neurosurgery, Dietrich-Bonhoeffer-Klinikum, Salvador-Allende-Straße 30, 17036 Neubrandenburg, Germany.
  • Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

ORCID-Profile: Piotr Wojdasiewicz, Paweł Turczyn, Daryush Purrahman, Dariusz Szukiewicz

Zitieren

APA

Wojdasiewicz, P., Turczyn, P., Lach-Gruba, A., Poniatowski, Ł. A., Purrahman, D., Mahmoudian-Sani, M. R., & Szukiewicz, D. (2024). The Role of Rosavin in the Pathophysiology of Bone Metabolism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042117

Vancouver

Wojdasiewicz P, Turczyn P, Lach-Gruba A, Poniatowski ŁA, Purrahman D, Mahmoudian-Sani MR, et al. The Role of Rosavin in the Pathophysiology of Bone Metabolism. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042117

BibTeX
@article{Wojdasiewicz2024,
  author = {Wojdasiewicz, Piotr and Turczyn, Paweł and Lach-Gruba, Anna and Poniatowski, Łukasz A and Purrahman, Daryush and Mahmoudian-Sani, Mohammad-Reza and Szukiewicz, Dariusz},
  title = {The Role of Rosavin in the Pathophysiology of Bone Metabolism},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25042117}
}
Kostenlos starten →